ZANDUREALT

Zandu Pharmaceutical works Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ZANDUPHARM_LR_19022009.ZIP target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has submitted to the Exchange disclosure under Regulation 8A(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations 1997. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Zandu_Pledge_11022009.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has informed the Exchange regarding the outcome of the Annual General Meeting of the Company held on December 13, 2008. The details of the business transacted at the Annual General Meeting shall be available on the NSE website(http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Zandu_outcomeofAGM_19122008.ZIP target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has submitted to the Exchange a copy of the Notice of the Annual General Meeting of the Shareholders of the company to be held on December 13, 2008. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)<a href=/content/corporate/zandupharma_AGM_28112008.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended September 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). <a href=/content/corporate/Zandu_LR_20112008.zip target=NEW> For more details click here.</a>

Anand Rathi Financial Services Limited has submitted to the Exchange a copy of Post Offer Public Announcement published on November 03, 2008 with resepect to the Open Offer to acquire up to 1,61,280 equity shares representing up to 20% of the voting rights of The Zandu Pharmaceutical Works Limited (ZPWL) (Target Company) by Emami Limited (the Acquirer) and Bhanu Vyapaar Private Limited (BVPL), Suraj Viniyog Private Limited (SVPL), Diwakar Viniyog Private Limited (DVPL) and Suntrack Commerce Private Limited (SCPL) collectively referred to as the 'Persons Acting in Concert/ PACs' at a Offer Pric

Zandu Pharmaceutical Works Ltd. has submitted to the Exchange disclosures received in form D, as required under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/zandupharma_Reg_27102008.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has informed the Exchange that: "The Promoters of The Zandu Pharmaceutical alongwith family members has entered into Share Purchase Agreement with M/s Emami Ltd., pursuant to which M/s Emami Ltd. has acquired 146643 Equity shares comprising of 18.18% Equity share capital of the Company".

Emami Limited has informed the Exchange vide its letter dated October 15, 2008, that: "Pursuant to the settlement efforts initiated by the Hon'ble Company Law Board vide its order dated 22nd September, 2008, the Company has acquired, in terms of a Share Purchase Agreement entered with the existing promoters of The Zandu Pharmaceuticals Works Limited (Zandu) and their relatives, friends and associates, 146643 equity shares comprising of 18.18% of the total paid up capital of Zandu at a price of Rs 15,000/- (Rupees Fifteen Thousand only) per share and also a non compete fee of Rs 1500/- (Rupees

Girish G. Parikh, Representing Acquirer / Transferor (List attached) has informed the Exchange that they proposes to acquire 288134 Equity shares aggregating to 35.73% of the shares/voting rights of Zandu Pharmaceutical works Ltd. from Transferors (List attached). The mode of proposed acquisition is by way of Inter-se transfer and the date of proposed acquisition is after October 04, 2008. The proposed acquisition price per share is Market Price. The shareholding of Girish G. Parikh, Representing Acquirer / Transferors (List attached) after the proposed acquisition would be 288134 shares aggre

Anand Rathi Financial Services Limited has informed the Exchange that the Acquirer and PACs have revised the Offer Price under Regulation 26 of the Regulations from Rs. 15,000/- (Rupees Fifteen Thousand only) per equity share to Rs. 16,500/- (Rupees Sixteen Thousand Five Hundred Only) per equity share. Further, Anand Rathi Financial Services Limited has submitted to the Exchange a copy of Corrigendum to Public Announcement with reference to Open Offer to acquire up to 1,61,280 equity shares representing up to 20% of the voting rights of the Zandu Pharmaceutical Works Limited (ZPWL) (Target Com

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2008 . A copy of the Limited Review Report and the Company's observation on comments of auditors shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Zandu_LR_03102008.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has informed the Exchange that "Court of Civil Judge, (Jr,Division) Garhbeta, West Midnapore, West Bengal has passed on ,20th September 2008 an ex-parte order of ad-interim injunction, restraining the Company from holding the 89th Annual General Meeting of the Company scheduled to be held on 24th September 2008. The copy of order was served on the Company only today i.e. 24th September 2008. VIII Bench City Civil Court, Calcutta, has passed an ex-parte ad-interim order on 20th September 2008, for restraining the Company from holding the 89th Annual General Meeti

Anand Rathi Financial Services Limited has submitted to the Exchange a copy of Corrigendum to Public Announcement with reference to Open Offer to acquire up to 1,61,280 equity shares representing up to 20% of the voting rights of the Zandu Pharmaceutical Works Limited (ZPWL) (Target Company) by Emami Limited (Acquirer) and Bhanu Vyapaar Private Limited (BVPL), Suraj Viniyog Private Limited (SVPL), Diwakar Viniyog Private Limited (DVPL) and Suntrack Commerce Private Limited (SCPL) collectively referred to as the 'Person Acting in Concert/ PAC's at a Offer Price of Rs. 15,000/- (Rupees Fifteen

Zandu Pharmaceutical Works Ltd. has submitted to the Exchange a copy of the notice of AGM of the Company which was scheduled to be held on August 9, 2008 and was postponed consequent to the order of the Hon'ble High Court, Bombay Dated August 7, 2008 will now be held on September 24, 2008. A copy of the notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/zandu_res_02092008.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has informed the Exchange that: "The Company had filed a petition before the Hon'ble Company Law Board (CLB), Mumbai Bench in relation to the acquisition of shares of the Company by M/s Emami Limited, Persons Acting in Concert (PACs) and others. The Company has challenged the acquisition of shares on grounds that the acquisition of shares has violated the provisions of various laws such as the SEBI Act, 1992, SEBI Takeover Regulations, 1997, SEBI Insider Trading Regulations, 1992 and the Companies Act, 1956. The Company has asked the CLB for rectification of Reg

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on August 09, 2008.

Zandu Pharmaceutical Works Ltd. has informed the Exchange regarding the disclosure received by the company under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 1992 for sale of shares from following persons. (1) PHI Consultants Pvt. Ltd. (2) Sharmila Leasing and Investments Pvt. Ltd. (3) Soraya Investment & Trading Co. P. Ltd. (4) Devkumar Vaidya, Anita Vaidya & Neena Vaidya. (5) Anita Vaidya (6) Apsara Leasing and Finance Pvt. Ltd. (7) Devkumar Vaidya & Neena Vaidya (8) Devkumar Vaidya. (9) Neena Vaidya (10) Haresh Vaidya (HUF) Karta Devkumar H. Vaidya. T

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on June 10, 2008 have recommended Final Dividend of Rs.25/- per share. The Directors had already authorised payment of interim dividend of Rs.50/- per share on January 22, 2008.

Zandu Pharmaceutical Works Ltd. has informed the Exchange that Company have received the initial disclosure of detail of shares held by Emami Limited in Form A vide their letter dated May 29, 2008. Company has submitted Regulation under 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/zandu_Reg_10062008.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. had informed the Exchange regarding the Board of Directors meeting to be held on June 06, 2008 for considering, among other matters, the proposal for issue of equity shares / warrants / other convertible instruments to promoters, their relatives, associates, other investors on preferential basis, subject to approval of members in the general meeting. The Company has now informed the Exchange that "Board of Directors in its meeting held on 6th June 2008, discussed and dropped the proposal".

Anand Rathi Financial Services Limited has informed the Exchange regarding a Public Announcement ("PA") being issued by Anand Rathi Financial Services Limited (formerly known as Anand Rathi Securities Limited) ("ARFSL" or "Manager to the Offer") on behalf of Emami Limited (herein after referred to as the "Emami" or "Acquirer") and Bhanu Vyapaar Private Limited ("BVPL"), Suraj Viniyog Private Ltd ("SVPL"), Diwakar Viniyog Private Limited ("DVPL") and Suntrack Commerce Private Limited ("SCPL") (herein after collectively referred to as the 'Persons Acting in concert/ PACs') pursuant to and in com

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Company has announced Book Closure from July 07, 2008 to July 11, 2008 for the purpose of Payment of Final Dividend on Equity Shares, if any.

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Company will be publishing Audited Financial results for the year ended March 31, 2008 before June 30, 2008. In view of the above, the Company does not propose to publish the unaudited result for the last quarter ended March 31, 2008.

Zandu Pharmaceutical Works Ltd. has submitted to the Exchange the auditor's report in respect of the unaudited financial results for the quarter and nine months ended December 31, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ZanduPharma_AR_28012008.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. had informed the Exchange regarding Record Date as January 28, 2008 for the purpose of Interim Dividend. The Company has now informed the Exchange that the Record Date has been changed to January 29, 2008 from earlier January 28, 2008.

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Board of Directors, at its meeting held on January 22, 2008 has recommended an interim dividend of Rs.50/- per equity share on face value of Rs.100/- each aggregating to Rs.471.72 Lakhs including dividend distribution tax of Rs.68.52 Lakhs.

Zandu Pharmaceutical Works Ltd. has informed the exchange regarding the outcome of the Annual General Meeting of the Company held on September 29, 2007. The details of the business transacted at the Annual General Meeting shall be available on the NSE website(http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ZANDU_AGM_01102007.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended June 30, 2007 . A copy of the Limited Review Report and the Company's observation on comments of auditors shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ZanduPhar_LR_13092007.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has informed the Exchange that in the Board Meeting held on August 28, 2007, the Board of Directors have recommended One Time Special Dividend of Rs. 15/- per share. The Directors had already authorised payment of interim dividend of Rs. 75/- per share on March 10, 2007.

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Company has announced Book Closure from September 8, 2007 to September 12, 2007 for the purpose of Payment of Dividend on Equity Shares, if any.

Zandu Pharmaceutical Works Ltd. has informed the Exchange that "Board of Directors in its meeting held on 10th March, 2007 has declared Interim Dividend of Rs. 75/- per share". The record date for the same is March 17, 2007

Zandu Pharmaceutical Works Ltd. has informed the Exchange that "Meeting of the Board of Directors of the Company scheduled to be held on Sunday, 25th February 2007 is postponed. Record date which was kept for declaration of interim dividend of 2nd March 2007, stands cancelled".

Zandu Pharmaceutical Works Ltd. has informed the Exchange that "The Board of Directors on 23rd January, 2007 approved the allotment of bonus shares in the ratio of 1:3 i.e. one new equity shares for every three existing equity shares held by members. After completion of all formalities, the bonus shares were listed and admitted to dealing by Bombay Stock exchange and National Stock Exchange on 8th February, 2007. All the fractional shares have been dealt as per unanimous resolution passed by the shareholders in 87th Annual General Meeting held on 26th December, 2006 and the same has been sold,

Zandu Pharmaceutical Works Ltd. has informed the Exchange that: "Board of Directors in its meeting held on 23rd January, 2007 had approved the Allotment of Bonus Shares in the ratio of 1:3 i.e. one new equity share for every three existing equity shares held by the members, considering the record date as 20th January, 2007".

Zandu Pharmaceutical Works Ltd. has submitted to the Exchange the summary of financial results. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/zandu_FR_240107.zip target=NEW> For more details click here.</a>

News Verification : The media had reports that Zandu Pharmaceutical Works Ltd. is setting up a unit at the Pantnagar industrial estate in Uttarakhand. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Zandu Pharmaceutical works Ltd. has vide its letter inter-alia stated, "Please note that the company is setting up a new unit in Uttaranchal and not at Himachal Pradesh as stated in the news article, at a total cost of

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the company has fixed January 20,2007 as the Record Date for the purpose of Issue of Bonus Shares in the ratio of 1:3 i.e. 1 additional equity share for every 3 existing equity shares.

Zandu Pharmaceutical Works Ltd. has submitted to the Exchange a certified true copy of the extracts of the Minutes of the Annual General Meeting held on December 26,2006. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/ZanduPhar_PR_08012007.zip target=NEW> For more details click here.</a>

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the members at the AGM of the company held on December 26, 2006, inter alia, have approved issue of bonus shares in the ratio of 1:3 i.e. 1 additional equity share for every 3 existing equity shares.

Zandu Pharmaceutical Works Ltd. has informed the Exchange that the Company has announced Book Closure from December 02, 2006 to December 05, 2006 for the purpose of payment of final dividend of Rs. 5/- per share.

Zandu Pharmaceutical Works Ltd. has informed the Exchange that in the Board meeting held on November 16, 2006, the Board of Directors have: 1)Taken on record annual audited accounts for March 31, 2006.2)Recommended the issue of bonus shares in the ratio of 1:3 i.e 1 additional shares for every 3 existing equity share held by the members.3)Proposed final dividend of Rs. 5/- per share, raising the total dividend for the year as a whole to Rs. 75/- per share (inclusive of Rs. 70/- per share of 2 interim dividends of Rs. 35/- each).

Zandu Pharmaceutical Works Ltd. had informed the Exchange that the Board of Directors of the Company at its meeting held on September 23, 2006 have approved the proposal of acquiring share from the shareholders of Zandu Chemicals Ltd. On implementation of the proposal, Zandu Chemicals Ltd will become the subsidiary of The Zandu Pharmaceuticals Works Ltd. The company has now informed the Exchange that Zandu Chemicals Ltd. has become the subsidiary of the company w.e.f. November 01,2006 as the company has further acquired 44.20% of equity share capital of Zandu Chemicals Ltd. The total holding

Zandu Pharma Works Ltd has informed the Exchange that the Board of Directors have appointed : 1) Shri Padmanabh Pundrikray Vora, 2) Prof. (Dr.) Sukhdev Swami Handa as Additional Directors.

Zandu Pharma Works Ltd has informed the Exchange that the Board of Directors of the Company at its meeting held on September 23, 2006 have approved the proposal of acquiring share from the shareholders of Zandu Chemicals Ltd. On implementation of the proposal, Zandu Chemicals Ltd will become the subsidiary of The Zandu Pharmaceuticals Works Ltd.

Zandu Pharma Works Ltd has informed the Exchange that the Company has obtained the statutory requisite approval from the Registrar of Companies for extension of time to hold the AGM of the Company for the financial year ended March 31, 2006, till December 31, 2006.

Zandu Pharma Works Ltd has informed the Exchange the BoDs in its meeting held on March 09, 2006 has declared 2nd interim dividend of Rs.35/- per share.

Zandu Pharma Works Ltd has informed the Exchange that the Company has fixed March 16, 2006 as Record Date for the purpose of 2nd Interim Dividend, if any.

Zandu Pharma Works Ltd has informed the Exchange that the BODs in its meeting held on December 12, 2005 has declared Interim Equity Dividend of Rs.35/- per share.

Zandu Pharma Works Ltd has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended September 30, 2005 and the details of the same are available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).